TIGIT and neoplasm: However, immunosuppressive tumor-associated macrophages (TAMs) remained prevalent and expressed ligands for alternative checkpoints such as CTLA-4 and TIGIT, suggesting that targeting these pathways may be necessary to overcome TAM-mediated suppression and improve anti-tumor immunity.